Rita Levi-Montalcini

(redirected from Rita Levi Montalcini)

Levi-Montalcini, Rita

(lā`vē-mŏn'təlsē`nē), 1909–2012, Italian-American neurologist, b. Turin, Italy, M.D. Univ. of Turin, 1936. A dual citizen of Italy and the United States, Levi-Montalcini did her most important work with Stanley CohenCohen, Stanley,
1922–, American biochemist, b. New York City, Ph.D. Univ. of Michigan, 1948. Cohen did his most important work at Washington Univ. with Rita Levi-Montalcini in the 1950s.
..... Click the link for more information.
 at Washington Univ., where she was a professor from 1956 to 1977. Studying mouse tumors implanted in chicken embryos, the pair isolated a nerve growth factor, the first of many cell growth factors found in animals; some of these were also first described by Levi-Montalcini and by Cohen. The discovery of nerve growth factor radically changed the study of cell growth and development. For this discovery Levi-Montalcini and Cohen were awarded the 1986 Nobel Prize in Physiology or Medicine.


See her autobiography, In Praise of Imperfection (1988).

Levi-Montalcini, Rita

(1909–  ) neurobiologist; born in Turin, Italy. While a practicing physician, she resisted German occupation by hiding in Florence and aiding war refugees (1943–45). She taught at the University of Turin (1945–47), then came to the U.S.A. to join Washington University (St. Louis) (1947–77). Her studies of nerve growth factor, isolated in 1952 from cultures of mouse tumor cells, won Levi-Montalcini and collaborator Stanley Cohen the 1986 Nobel Prize in physiology or medicine. She divided her time between the U.S.A. and the National Research Council in Rome (1961–89), then moved to Rome permanently to be with her twin sister (1989).
References in periodicals archive ?
The candidate drug, developed in Italy in the L'Aquila laboratories of the Biopharmaceutical Group, finds its origins in the research of Nobel Prize winner Rita Levi Montalcini.
NGF (Nerve Growth Factor) was discovered by Rita Levi Montalcini, who was awarded the Nobel Prize in Physiology or Medicine in 1986.
Name:Bernardo LOPEZ ROMANO (Mr) Avda Rita Levi Montalcini (Tecnogetafe) 29
Rita Levi Montalcini, the Italian-Jewish scientist, physician, and neurobiologist who won a Nobel Prize for Medicine in 1986 with her colleague Stanley Cohen for the discovery of how cells selectively prune and communicate with each other, died on Sunday at the age of 103 in her native Italy.
Through the centuries, figures like Leonardo, Galileo Galilei, Alessandro Volta, then Enrico Fermi and Guglielmo Marconi until to the contemporaries Carlo Rubbia, Nicola Cabibbo, Rita Levi Montalcini (just to cite few names) testify to a culture that made Italy great in the world: the same culture that still today represents the most precious heritage for the young generations.
Rita Levi Montalcini, Nobel Prize Winner for Medicine in 1986, was born in Turin on April 22, 1909, but Milan will be celebrating the birthday in advance, tomorrow and Saturday.
Elogio dell'imperfezione, opera di Rita Levi Montalcini apparsa nel 1988, e trattata nel quarto capitolo.
In 2012, Dompe acquired Anabasis, an Italian biotech company that develops innovative drugs based on rhNGF (whose discovery earned Professor Rita Levi Montalcini the Nobel Prize for Medicine) for serious eye diseases for which there are no effective treatments available.
rhNGF is the first clinical application of the research carried out by Rita Levi Montalcini (winner of the Nobel Prize for Medicine in 1986) on Nerve Growth Factor.
These results are of great importance in the course of the clinical development of rhNGF, a candidate drug that originates from the research carried out by Nobel Prize winner Rita Levi Montalcini," explains Eugenio Aringhieri, CEO of the Dompe Group .
Previous Pio Manzu Center medals have been awarded to Henry Kissinger, Gro Brundtland (former Prime Minster of Norway), Lady Diana, Javier Perez De Cuellar (former UN Secretary General), and Nobel Laureate Rita Levi Montalcini, for their work for "the future of the Earth and active contribution to social development, peace and human progress.
Recombinant human Nerve Growth Factor (rhNGF), developed and manufactured by the Dompe Group and based on the research ofNobel Prize winner Rita Levi Montalcini, recently received orphan drug designation from the European Medicines Agency (EMA) and the United States FDA regulatory agencies for the treatment of Retinitis pigmentosa.